SEPN
Septerna Inc
NASDAQ · Pharmaceuticals
$25.41
+0.97 (+3.97%)
Open$24.73
Previous Close$24.44
Day High$25.76
Day Low$24.13
52W High$30.50
52W Low$4.17
Volume—
Avg Volume299.8K
Market Cap1.14B
P/E Ratio—
EPS$-1.51
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
+76.9% upside
Current
$25.41
$25.41
Target
$44.96
$44.96
$33.78
$44.96 avg
$58.81
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.87M | 203.59M | 209.55M |
| Net Income | -325,006,928 | 62.98M | 65.23M |
| Profit Margin | -6,678.9% | 30.9% | 31.1% |
| EBITDA | -359,926,322 | 113.38M | 119.42M |
| Free Cash Flow | — | 53.53M | 45.52M |
| Rev Growth | — | +1.5% | +13.6% |
| Debt/Equity | — | 0.24 | 0.25 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |